Skip to content

Trial Summary

A phase II clinical trial of nivolumab monotherapy in previously treated recurrent or metastatic microsatellite instability high (MSI-H) colorectal cancer.



ACTRN/NCT /ethics:


Scientific title:


Trial & Patient Characteristics

Cancer TypeBowel
Trial TypeTreatment
PhasePhase II
Age Range18+ years
Tumour StreamColorectal cancer
Cancer StageLocally Recurrent or Locally Advanced, Matastatic or Widespread
Anticipated Start Date2019-07-01
Anticipated End Date2020-11-30

Participating Hospitals

HospitalCalvary Central Districts Hospital
Clinical Trial CoordinatorJulie Rowe
Phone08 8239 9536
Principal InvestigatorDr Rohit Joshi
Recruitment StatusRecruiting